BRASILIA, Brazil — An analysis of prespecified subgroups in the third International Stroke Trial (IST-3) shows that intravenous recombinant tissue plasminogen activator (rtPA) can be given safely in a ...
The clinical syndrome produced by a stroke is determined by the artery or arteries that are occluded. Blood is supplied to the brain by two major sets of arteries, the anterior and posterior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback